Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US5834592A · kind A · utility
18Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 1995 |
| Grant date | Nov 10, 1998 |
| Priority date | — |
| Expiry date | Sep 22, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/806
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for preventing, treating and detecting leishmaniasis and stimulating immune responses in patients are disclosed. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens, or a variant thereof. Vaccines and pharmaceutical compositions comprising such polypeptides are also provided and may be used, for example, for the prevention and therapy of leishmaniasis, as well as for the detection of Leishmania infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.